Navigation Links
Women Affected With VWD is one of the Reason for Heavy Periods

Von Willebrand's Disease (VWD) is an inherited condition affecting about 1% of the female population. Women with heavy periods could be affected by this bleeding// disorder which goes undetected. Only about 5,000 women have been diagnosed in the UK.

A survey of 600 women aged 16-45 for the Haemophilia Society says that about only 70% approach their GP with this problem. Von Willebrand's Disease (VMD) is a condition which leads to heavy or prolonged menstrual flow. Apart from this the other symptoms are heavy nosebleeds, bruise easily and lengthy bleeding from small cuts and scratches. The Haemophilia Society says that women often think that the heavy periods they share with other members of their family are normal as it is inherited. But the seriousness is understood only when excessive bleeding occurs after an operation or during childbirth. It is at this time that the diagnosis of such a disease brings to light about the dangers of the disease.

Margaret Unwin, chief executive of the Haemophilia Society, said that about 98% of women affected by VWD remain unaware of their condition. Debra Pollard, clinical nurse specialist in haemophilia at London's Royal Free Hospital, said that if a woman’s period lasts for more than seven days and is very heavy with the passage of clots then it is high time that she seeks medical advice. Peter Bowen-Simpkins, a spokesman for the Royal College of Obstetricians and Gynaecologists, said that Von Willebrand's Disease is something that is serious and can cause huge problems if left undiagnosed.


'"/>




Page: 1

Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... ... Cellairis is a worldwide mobile device and computer repair franchise that is known ... Samsung Galaxy devices with premium parts and accessories. Cellairis has recently set-up for business ... customers. While customers do their shopping, Cellairis can accomplish a number of mobile device ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, ... safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP FOR ... easy to use and could be set up in a matter of minutes, or ...
(Date:12/9/2016)... Harrisburg, PA (PRWEB) , ... December 09, 2016 ... ... concussion education program through the Pennsylvania Cable Network (PCN) during the summer of ... Brain Injury Implementation Grant provided by the United States Department of Health and ...
(Date:12/8/2016)... ... 2016 , ... ZyDoc , a New York-based medical ... Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” has ... usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ natural ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: